Archives: Agenda

• Understanding the complexities and challenges of the end-to-end pharmaceutical supply chain, from manufacturing to patient delivery
• Addressing regulatory requirements and compliance
• How did we implement effective strategies to enhance the end-to-end pharmaceutical supply chain

• Market Outlook
• IATA Standards Setting & TCR Regulations
• IATA Pharma Solutions

• In H1, trial initiations significantly increased in comparison to previous years
• Explore the latest trial trends, challenges, and opportunities for suppliers shaping clinical trials this year
• See how this has shaken up the biopharma competitive landscape and how this will affect the clinical trial supply chain

• This presentation explores how AR1001 is poised to redefine the Alzheimer’s disease (AD) treatment landscape as a first-in-class, oral, disease-modifying therapy — bringing fresh momentum to a field that has seen limited progress over the past two decades
• We will delve into the scientific breakthroughs and strategic learnings gained through years of innovation and perseverance within the highly challenging global AD space
• Finally, we spotlight AriBio’s commitment to delivering the right therapy to the right patients at the right time, while upholding rigorous global regulatory and quality standards to support successful approvals in both the U.S. (FDA) and Europe (EMA)

• Real-world challenges in IP (Investigational Product) supply management – balancing safety, compliance, and cost in global trials
• Adaptive strategies to prevent stockouts and manage variable recruitment
• Enhancing operational efficiency through optimized IRT configurations
• Leveraging modeling and simulation tools to forecast demand and reduce waste